secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001558370-23-012422
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma issues $2.4M 25% senior secured convertible note due July 2024
--------------------------------------------------------------------------------

- Principal amount of $2,400,000 with 25% annual interest (27% upon default), matures July 25, 2024.
- Convertible into common stock at $6.50 per share, subject to 9.99% beneficial ownership cap.
- Secured by all of the company's fixtures, equipment, and intellectual property.
- Issued to an accredited investor in reliance on Section 4(a)(2) exemption.
- Prepayment permitted without penalty; Holder may convert after prepayment notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023012422/0001558370-23-012422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023012422/krbp-20230727x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-012422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer